<qa>  What is the oral thrombin inhibitor?5. Patients using fondaparinux sodium or the oral thrombin inhibitor, ximelagatran, or are expected to be treated with fondaparinux sodium or ximelagatran during the study period up to 7 days after stop of treatment. 